Literature DB >> 12972489

Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.

M Jinnin, H Ihn, Y Asano, K Yamane, N Yazawa, K Tamaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12972489      PMCID： PMC1754308          DOI： 10.1136/ard.62.10.1019

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy.

Authors:  Predrag Ostojic; Nemanja Damjanov
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

2.  Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Takashi Niimi; Yuji Ohtsuki; Jiro Fujita; Hiroyoshi Maeda; Shigeki Sato; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2006-11-24       Impact factor: 4.064

Review 3.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

Review 4.  Antifibrosis: to reverse the irreversible.

Authors:  Ziv Paz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.